KLOW Blend Reconstitution Chart (Every Vial Size)

Overview of KLOW Blend in Laboratory Research

The KLOW blend is a specialized four-peptide research complex comprising BPC-157, TB-500, GHK-Cu, and KPV. In preclinical models, these constituent peptides are investigated for their synergistic roles in cellular migration, extracellular matrix remodeling, tissue repair pathways, and localized inflammatory response modulation. Because the constituent components possess distinct molecular weights and chemical profiles, maintaining exact concentration parameters during reconstitution is vital for consistent bench-top reproducibility.

When sourcing high-purity research compounds, investigators require precise analytical verification. PX1 Research manufactures all research peptides in USA-based, ISO 17025 accredited facilities, subjecting every lot to HPLC and mass spectrometry (MS) testing to confirm identity and high purity. Researchers interested in obtaining this quad-component formulation can review the technical specification sheet for our BPC-157 + TB-500 + GHK-Cu + KPV (KLOW Blend 80mg).

Reconstitution Formula and Mathematical Derivations

To calculate the total active peptide concentration of a reconstituted KLOW blend vial, bench investigators apply standard volumetric concentration equations. Total peptide concentration ($C$) in milligrams per milliliter (mg/mL) is derived by dividing the total active mass of the lyophilized cake ($M$) in milligrams by the volume of added diluent ($V$) in milliliters:

$$C = \frac{M}{V}$$

To determine the specific volumetric yield per 0.1 mL (100 µL) aliquot—a standard unit of measure in micro-pipetting and automated assay dispensing—multiply the final concentration by 0.1 mL:

$$\text{Mass per 0.1 mL} = C \times 0.1 = \frac{M}{10 \times V}$$

Because the KLOW blend consists of four distinct peptides expressed as a combined mass (such as an 80 mg total vial containing 10 mg BPC-157, 10 mg TB-500, 50 mg GHK-Cu, and 10 mg KPV), the proportional concentration of any single constituent peptide can be derived by multiplying its baseline mass ratio by the calculated final volumetric concentration. Researchers needing automated volumetric calculations across custom vial dimensions can utilize our interactive reconstitution calculator.

Master KLOW Blend Reconstitution Table

The table below details final total compound concentrations (mg/mL) and per-0.1 mL volumetric yields for common total vial masses (80 mg and 40 mg) across standard laboratory diluent volumes. All calculations assume complete dissolution in standard diluents such as Bacteriostatic Water (0.9% Benzyl Alcohol) or Sterile Normal Saline (0.9% NaCl).

| Total Vial Mass (mg) | Added Diluent Volume (mL) | Resulting Total Concentration (mg/mL) | Total Yield per 0.1 mL (100 µL) | GHK-Cu Yield per 0.1 mL (approx) | BPC / TB / KPV Yield per 0.1 mL (each) | |---|---|---|---|---|---| | 80 mg | 1.0 mL | 80.0 mg/mL | 8.0 mg | 5.0 mg | 1.0 mg | | 80 mg | 2.0 mL | 40.0 mg/mL | 4.0 mg | 2.5 mg | 0.5 mg | | 80 mg | 3.0 mL | 26.67 mg/mL | 2.67 mg | 1.67 mg | 0.33 mg | | 80 mg | 4.0 mL | 20.0 mg/mL | 2.0 mg | 1.25 mg | 0.25 mg | | 80 mg | 5.0 mL | 16.0 mg/mL | 1.6 mg | 1.0 mg | 0.2 mg | | 40 mg | 1.0 mL | 40.0 mg/mL | 4.0 mg | 2.5 mg | 0.5 mg | | 40 mg | 2.0 mL | 20.0 mg/mL | 2.0 mg | 1.25 mg | 0.25 mg | | 40 mg | 4.0 mL | 10.0 mg/mL | 1.0 mg | 0.625 mg | 0.125 mg |

Investigators cataloging multiple research compounds across active laboratory protocols can browse our complete catalog of all peptides for comprehensive molecular weights, storage parameters, and structural data.

Worked Example 1: Standard Reconstitution (80 mg Vial + 2.0 mL Diluent)

Consider a laboratory scenario where an investigator needs to reconstitute a single vial of 80 mg KLOW blend using 2.0 mL of Bacteriostatic Water. The objective is to determine both the total peptide concentration and the specific quantity of GHK-Cu per 0.1 mL pipette dispense.

1. **Calculate Total Concentration ($C$):** Divide total mass ($M = 80\text{ mg}$) by diluent volume ($V = 2.0\text{ mL}$): $$C = \frac{80\text{ mg}}{2.0\text{ mL}} = 40.0\text{ mg/mL}$$

2. **Calculate Total Mass per 0.1 mL Aliquot:** Multiply total concentration by 0.1 mL: $$\text{Total Yield} = 40.0\text{ mg/mL} \times 0.1\text{ mL} = 4.0\text{ mg}$$

3. **Determine Constituent Mass (GHK-Cu):** In an 80 mg total vial, GHK-Cu represents 50 mg of the total mass (a ratio of $50/80 = 0.625$). Multiply the 0.1 mL total yield by $0.625$: $$\text{GHK-Cu Yield} = 4.0\text{ mg} \times 0.625 = 2.5\text{ mg}$$

This standard 2.0 mL dilution protocol yields a highly manageable solution viscosity, suitable for precise micro-titration in cell culture assays.

Worked Example 2: Low-Concentration Dilution for In Vitro Assays (80 mg Vial + 4.0 mL Diluent)

In high-throughput cell culture screen protocols, a lower concentration may be required to minimize pipetting margin-of-error when transferring sub-milligram quantities into multi-well plates. Here, an investigator reconstitutes an 80 mg KLOW vial with 4.0 mL of sterile saline solution.

1. **Calculate Total Concentration ($C$):** $$C = \frac{80\text{ mg}}{4.0\text{ mL}} = 20.0\text{ mg/mL}$$

2. **Calculate Total Mass per 0.1 mL Aliquot:** $$\text{Total Yield} = 20.0\text{ mg/mL} \times 0.1\text{ mL} = 2.0\text{ mg}$$

3. **Determine Constituent Mass (BPC-157, TB-500, or KPV):** Each of these three peptides represents 10 mg of the 80 mg total mass ($10/80 = 0.125$). Multiply the total yield by $0.125$: $$\text{Constituent Yield} = 2.0\text{ mg} \times 0.125 = 0.25\text{ mg} \text{ (250 µg)}$$

A 4.0 mL dilution facilitates high precision when micro-pipetting working stocks into aqueous media for short-term in vitro incubation models.

Diluent Selection: Bacteriostatic Water vs. Sterile 0.9% Sodium Chloride

Choosing an appropriate diluent depends directly on the planned analytical assay duration and storage timeline. Bacteriostatic Water containing 0.9% benzyl alcohol is the standard diluent for multi-use research vials intended for storage over several days or weeks at 2–8°C, as the preservative prevents bacterial proliferation.

Conversely, when conducting immediate in vitro bioassays or enzymatic assays where benzyl alcohol might interfere with cell viability or receptor binding kinetics, unpreserved Sterile 0.9% Sodium Chloride or Phosphate-Buffered Saline (PBS) is preferred. Vials reconstituted with preservative-free diluents should be utilized immediately or single-use aliquoted and frozen to preserve compound integrity.

Comparative Analysis: KLOW Blend vs. Individual Peptides

Laboratory researchers frequently compare multi-component peptide complexes against individual research isolates to evaluate experimental controls. For example, evaluating single-agent BPC-157 or standalone TB-500 allows investigators to isolate specific intracellular signaling cascades, such as FAK/Paxillin phosphorylation or actin sequestration. Similarly, evaluating isolated GHK-Cu provides controlled baseline data for copper-dependent gene transcription assays without interaction from secondary peptide sequences.

Combining these agents into a unified complex like the KLOW blend reduces multi-vial pipetting variability, minimizes volumetric preparation steps, and standardizes constituent exposure ratios across experimental trial groups.

Laboratory Handling and Solubilization Techniques

Lyophilized peptide cakes should be brought to room temperature prior to diluent introduction to prevent moisture condensation within the vial. When introducing diluent, direct the liquid stream against the glass vial wall rather than spraying directly onto the lyophilized powder mass. This reduces violent turbulence and prevents foaming or protein denaturation.

Swirl the vial gently with a slow, circular motion until the cake completely dissolves into a clear solution. Never vortex peptide solutions vigorously, as mechanical shear forces can disrupt tertiary structures and induce peptide aggregation. Due to the presence of GHK-Cu, fully dissolved KLOW blend solutions exhibit a characteristic light blue coloration.

Quality Verification: HPLC, MS, and Endotoxin Standards at PX1 Research

Experimental accuracy depends entirely on the analytical chemical purity of the research reagents. Impurities, peptide fragments, or residual synthesis solvents can skew cell culture assays and alter binding affinities. Every batch of KLOW blend produced for PX1 Research undergoes stringent quality testing in GMP-compliant facilities.

Analytical verification includes High-Performance Liquid Chromatography (HPLC) to establish purity (>99%), Mass Spectrometry (MS) to confirm exact molecular mass, and chromogenic LAL assays to ensure endotoxin levels remain strictly below <0.01 EU/mg. Investigators can download lot-specific analytical reports directly through our official Certificate of Analysis (COA) repository.

Storage Conditions and Aliquot Stability Protocols

Unreconstituted lyophilized KLOW blend vials should be stored in a commercial freezer at -20°C (or -80°C for long-term storage exceeding 12 months), protected from light exposure. In this state, the peptide complex remains chemically stable for extended periods without significant degradation.

Following reconstitution with Bacteriostatic Water, the liquid solution should be maintained under refrigeration at 2°C to 8°C and utilized within 28 days. For extended usage timelines beyond 30 days, researchers should aliquot the reconstituted solution into sterile polypropylene micro-centrifuge tubes and freeze at -20°C to prevent freeze-thaw degradation cycles. For institutional procurement and bulk facility supply requirements, visit our wholesale research portal.